Vaccine comprising epitope of heat shock protein, and use thereof
AssigneeAston Sci. Co., Ltd.
InventorsKyong Hwa PARK, Jin Ho KANG
Life of this patent
Estimating the term…
Abstract
A vaccine containing an epitope of a heat shock protein 90 and uses thereof are disclosed. The epitope(s) of heat shock protein 90 has the amino acid sequence of SEQ ID NO: 1 and/or 2. A multi-epitope vaccine containing the epitope(s) and a method for treating or preventing cancer using the same are disclosed.
Claims15
1-20. (canceled)
A method for treating or preventing cancer in a subject in need thereof, comprising administering to the subject an effective amount of a composition,
- wherein the composition comprises a mixture of two different MHC class II-specific epitopes from a heat shock protein 90 (HSP90),
- wherein the two MEW class II-specific epitopes consist of the amino acid sequence of SEQ ID NO:
- 1 and the amino acid sequence of SEQ ID NO:
- 2.
A method for treating or preventing cancer in a subject in need thereof, comprising administering to the subject an effective amount of a composition,
- wherein the composition comprises an isolated heat shock protein 90 (HSP90)-specific MHC class II epitope,
- wherein the epitope consists of a peptide selected from the group consisting of SEQ ID NOs:
- 1, 2, 5, 6, 7, 8, 9, 10, 11, 12, 13, and 14.
A method for treating or preventing cancer in a subject in need thereof, comprising administering to the subject an effective amount of a composition,
- wherein the composition comprises nucleic acid molecule encoding an epitope consisting of a peptide selected from the group consisting of SEQ ID NOs:
- 1, 2, 5, 6, 7, 8, 9, 10, 11, 12, 13, and 14.
Dependencies are inferred from the claim text.